The Administration to Help the Supreme Court Decide on a Case

The U.S. Supreme Court has asked the Obama administration for its views on a rule (Biologics Price Competition and Innovation Act) that will determine when lower-cost biosimilar medicines can be launched. Read article here…..

 

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.